Berlin, Germany

Michael Niedermaier



 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael Niedermaier: Innovator in Pharmaceutical Chemistry

Introduction

Michael Niedermaier is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of specific compounds. With a total of 3 patents to his name, Niedermaier continues to push the boundaries of medical science.

Latest Patents

Niedermaier's latest patents include the development of a new crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt. This invention not only provides a novel crystalline form but also outlines its use for medical purposes. Additionally, he has patented two distinct crystalline forms of the same compound, which exhibit differing immunological effects. These properties are particularly advantageous for immunospecific applications and enhance the physicochemical characteristics necessary for pharmaceutical preparations.

Career Highlights

Throughout his career, Michael Niedermaier has been associated with Metriopharm AG, where he has played a crucial role in advancing pharmaceutical research. His work has been instrumental in developing new formulations that can improve patient outcomes and therapeutic efficacy.

Collaborations

Niedermaier has collaborated with notable colleagues such as Thomas Martin and Josef Breu. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Michael Niedermaier stands out as a key figure in the realm of pharmaceutical innovations. His contributions through patents and collaborations continue to shape the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…